1 Product identity
Ingredient risk
Contains restricted ingredients
Ashwagandha 450 mg
BrandVitabase→Botanical Other (e.g. tea bag) 4 ingredients 1 banned 1 caution DSLD #5488Net contents: 90 Vcap(s)(R)
Target: Adults and Children 4 years and above
DSLD entry: 2012-03-23
2 Ingredients (4)
IngredientGroupSafety
Rice FlourRice—
Cellulosecapsule—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
5 Data source
DSLD ID5488
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-03-23
6 More from Vitabase
View Vitabase Safety Scorecard → 264 products
Acai BerryAcetyl L-CarnitineAcid ComfortAcid ReduxAcidophilusAcidophilus7 Cite this page
Vancouver
Pkhakadze G. Ashwagandha 450 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 28]. Available from: https://supplement.ge/products/ashwagandha-450-mg-5488/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG